A Study of SKB264 Versus Investigator's Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
Clinical trial NCT06279364 · RECRUITING
Trial details
- NCT number
- NCT06279364
- Sponsor
- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-28
- Primary completion
- 2026-07-01
- Enrollment
- 524
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.